- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
189
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
189 companies
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.96
7D
-2.3%
1Y
211.6%
EZZ Life Science Holdings
Market Cap: AU$104.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.21
7D
1.4%
1Y
-41.2%
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥10.8b
Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.
600572
CN¥4.36
7D
-2.5%
1Y
-0.7%
Hyphens Pharma International
Market Cap: S$115.8m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.38
7D
1.4%
1Y
29.3%
Tong Ren Tang Technologies
Market Cap: HK$6.2b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.80
7D
-2.6%
1Y
-7.3%
Beit Jala Pharmaceutical
Market Cap: د.أ19.6m
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
BJP
د.أ2.80
7D
0%
1Y
n/a
Puma Biotechnology
Market Cap: US$237.2m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$4.72
7D
8.8%
1Y
85.1%
Rhone Ma Holdings Berhad
Market Cap: RM 147.6m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.65
7D
-2.3%
1Y
-11.0%
Medical Developments International
Market Cap: AU$74.4m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.67
7D
-0.7%
1Y
55.8%
Jerusalem Pharmaceuticals
Market Cap: US$72.0m
Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.
JPH
US$4.00
7D
0.3%
1Y
10.5%
SSY Group
Market Cap: HK$8.8b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.96
7D
-1.7%
1Y
-24.3%
Arterra Bioscience
Market Cap: €18.4m
A research-based biotech company, engages in the research and development of various ingredients and natural solutions.
ARBS
€2.76
7D
-0.7%
1Y
46.8%
Vita Life Sciences
Market Cap: AU$134.6m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.44
7D
-4.7%
1Y
13.0%
Trajan Group Holdings
Market Cap: AU$114.4m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.74
7D
0%
1Y
-40.8%
Pak Fah Yeow International
Market Cap: HK$763.5m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.47
7D
-0.4%
1Y
-4.3%
Kotra Industries Berhad
Market Cap: RM 624.4m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 4.26
7D
0.2%
1Y
-2.3%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.14
7D
-1.4%
1Y
62.1%
Xenetic Biosciences
Market Cap: US$5.0m
A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.
XBIO
US$3.25
7D
-0.6%
1Y
-18.1%
Sopharma AD
Market Cap: лв1.4b
Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
SFA
лв2.71
7D
3.4%
1Y
36.0%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.22
7D
0.8%
1Y
8.0%
Aelis Farma
Market Cap: €15.0m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.10
7D
-20.9%
1Y
-77.0%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.017
7D
0%
1Y
41.7%
ECO Animal Health Group
Market Cap: UK£62.0m
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.
EAH
UK£0.92
7D
11.6%
1Y
-14.5%
1CM
Market Cap: CA$45.9m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.24
7D
-38.5%
1Y
-4.0%
Botanix Pharmaceuticals
Market Cap: AU$274.6m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.15
7D
20.0%
1Y
-60.5%
Birzeit Pharmaceuticals
Market Cap: US$143.8m
Manufactures and trades in various medicines in the Palestinian Authority.
BPC
US$3.71
7D
1.6%
1Y
-2.4%
Acrivon Therapeutics
Market Cap: US$49.7m
A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.
ACRV
US$1.56
7D
0%
1Y
-78.2%
Pharming Group
Market Cap: €877.0m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.28
7D
5.4%
1Y
85.0%
Lipocine
Market Cap: US$15.0m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$2.76
7D
-3.2%
1Y
-41.8%
Protalix BioTherapeutics
Market Cap: US$156.3m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.06
7D
10.2%
1Y
89.0%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.30
7D
-8.4%
1Y
93.3%
Pharmesis International
Market Cap: S$14.4m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.46
7D
0%
1Y
258.3%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥11.1b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.66
7D
-3.7%
1Y
6.1%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥6.6b
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
002390
CN¥3.45
7D
-4.7%
1Y
5.2%
AC Immune
Market Cap: US$249.3m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.73
7D
11.0%
1Y
-26.0%
Adagene
Market Cap: US$96.6m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$2.03
7D
-0.5%
1Y
-7.7%